Loading...
XJPX
4021
Market cap6.72bUSD
Jul 10, Last price  
8,100.00JPY
1D
-0.71%
1Q
27.52%
Jan 2017
107.43%
Name

Nissan Chemical Corp

Chart & Performance

D1W1MN
XJPX:4021 chart
P/E
21.85
P/S
3.89
EPS
370.65
Div Yield, %
2.15%
Shrs. gr., 5y
-1.35%
Rev. gr., 5y
5.98%
Revenues
279.59b
+11.23%
174,351,000,000169,172,000,000160,162,000,000149,036,000,000154,209,000,000148,578,000,000153,806,000,000163,658,000,000171,206,000,000176,894,000,000180,289,000,000193,389,000,000204,896,000,000206,837,000,000209,121,000,000207,972,000,000228,065,000,000226,705,000,000251,365,000,000279,586,000,000
Net income
49.71b
+15.49%
13,992,000,00015,503,000,00010,052,000,00012,751,000,00012,953,000,00010,975,000,00013,879,000,00016,701,000,00018,199,000,00022,350,000,00024,026,000,00027,143,000,00029,373,000,00030,780,000,00033,470,000,00038,777,000,00041,088,000,00038,034,000,00043,042,000,00049,708,000,000
CFO
64.16b
+8.43%
19,760,000,00018,973,000,00014,635,000,00026,575,000,00024,914,000,00021,903,000,00022,839,000,00023,759,000,00020,452,000,00029,989,000,00032,491,000,00037,691,000,00032,070,000,00035,550,000,00039,939,000,00041,949,000,00035,226,000,00033,701,000,00059,178,000,00064,164,000,000
Dividend
Sep 29, 202670 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Founded in Tokyo in 1887, Nissan Chemical Corporation conducts its diverse business operations both domestically in Japan and across international markets, specializing in four key areas: chemicals, performance materials, agricultural chemicals, and pharmaceuticals. The company's expansive chemical product line includes the adhesive agent MELAMINE, a variety of high-purity chemicals, the urea solution AdBlue, and foundational industrial compounds such as ammonia, sulfuric acid, and nitric acid. Other specialized chemical offerings feature TEPIC (an epoxy compound), Melamine Cyanurate (a salt of melamine and isocyanuric acid), phenylphosphonic acid, and HI-LITE (a chlorinated isocyanurate). Additionally, Nissan Chemical manufactures the health food Nissan Reishi, OPTBEADS (composed of melamine-formaldehyde resin and silica), and FINEOXOCOL (a saturated fatty alcohol and acid). Within its performance materials division, the corporation develops crucial materials for display technologies, semiconductors, and various inorganic applications. Its agricultural chemicals segment supplies a broad range of products, including herbicides, insecticides, and fungicides, utilized on farmlands, golf courses, and public parks. This division also produces active pharmaceutical ingredients for animal antiparasitic medications. In the pharmaceutical sector, Nissan Chemical markets prescription drugs such as LIVALO, which is used to reduce cholesterol, and LANDEL and FINTE, both dual-action calcium channel blockers. Beyond its proprietary pharmaceutical products, the company offers custom manufacturing and process research services for pharmaceutical ingredients. Looking towards future innovation, Nissan Chemical is actively engaged in developing solutions across healthcare, information and communication materials, and environmental and energy materials. The company, which was previously known as Nissan Chemical Industries, Ltd., officially changed its name to Nissan Chemical Corporation in July 2018.
IPO date
May 16, 1949
Employees
2,965
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT